Loading...

Purified anti-CD230 (Prion) Antibody (Previously Covance catalog# SIG-399810)

Pricing & Availability
Clone
6D11 (See other available formats)
Regulatory Status
RUO
Other Names
Major prion protein, p27-30, CD230 antigen, prion protein PrP, prion-related protein
Previously
Covance Catalog# SIG-399810
Signet Catalog# 9810-02
Signet Catalog# 9810-05
Signet Catalog# 9810-10
Isotype
Mouse IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
6D11_PURE_CD230_Antibody_081018
Human peripheral blood lymphocytes were stained with purified anti-CD230 (Prion) antibody (clone 6D11, filled histogram) or purified mouse IgG2a, κ isotype control (open histogram), followed by anti-mouse IgG PE.
  • 6D11_PURE_CD230_Antibody_081018
    Human peripheral blood lymphocytes were stained with purified anti-CD230 (Prion) antibody (clone 6D11, filled histogram) or purified mouse IgG2a, κ isotype control (open histogram), followed by anti-mouse IgG PE.
Compare all formats
Cat # Size Price Quantity Check Availability Save
808004 25 µL 132€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
808001 100 µL 423€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
808002 250 µL 792€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
808003 500 µL 1372€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Prions cause neurodegenerative disease by aggregating extracellularly within the central nervous system which disrupt the normal tissue structure. This disruption is characterized by "holes" in the tissue with resultant spongy architecture. Two conformational isoforms exist, the normal cellular isoform (PrPC) and the infectious, scrapie isoform (PrPSC). Other histological changes include astrogliosis and the absence of an inflammatory reaction. Neurodegenerative symptoms can include convulsions, dementia, ataxia (balance and coordination dysfunction), and behavioral or personality changes.

All known prion diseases are collectively called transmissible spongiform encephalopathies (TSEs). Prion (PrP) is highly conserved through mammals and comparison between primates ranges from 92.9-99.6% similarity in amino acid sequence. The human protein structure consists of a globular domain with three α-helices and a two-strand antiparallel β-sheet, an NH2-terminal tail, and a short COOH-terminal tail. A glycosylphosphatidylinositol (GPI) membrane anchor at the COOH-terminal tethers PrP to cell membranes. This anchor is integral to the transmission of conformational change; secreted PrP lacking the anchor component is unaffected by the infectious isoform. PrPSC accumulates in compact, protease-resistant aggregates within neural tissue and has a different secondary and tertiary structure from PrPC, but an identical primary sequence.

The primary sequence of PrP is 253 amino acids long before posttranslational modification. Signal sequences in the amino- and carboxy- terminal ends are removed posttranslationally, resulting in a mature length of 208. For human and Syrian hamster PrP, two glycosylated sites exist on helices 2 and 3 at Asn181 and Asn197. Murine PrP has glycosylation sites as Asn180 and Asn196. A disulfide bond exists between Cys179 of the second helix and Cys214 of the third helix (human PrPC numbering).

The precise function of PrP is not yet known, but it is possibly involved in the transport of ionic copper to cells from the surrounding environment. Researchers have also proposed roles for PrP in cell signaling or in the formation of synapses.

Spatial learning, a predominantly hippocampal-function, is decreased in PrP null mice and can be recovered with the reinstatement of PrP in neurons; indicating that loss of PrP function is the cause. PrP is present in both pre- and post-synaptic neuron cells, and the greatest concentration is in the pre-synaptic cells. Some research indicates PrP involvement in neuronal development, differentiation, and neurite outgrowth. The PrP-activated signal transduction pathway is associated with axon and dendritic outgrowth with a series of kinases.

Though most attention is focused on PrP’s presence in the nervous system, it is also abundant in immune system tissue. PrP immune cells include haematopoietic stem cells, mature lymphoid and myeloid compartments, and certain lymphocytes; also, it has been detected in natural killer cells, platelets, and monocytes. T cell activation is accompanied by a strong up-regulation of PrP, though it is not requisite. The lack of immuno-response to transmissible spongiform encephalopathies (TSE), neurodegenerative diseases caused by prions, could stem from the tolerance for PrPSc.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution; no preservatives or carrier proteins.
Preparation
This antibody was purified by affinity chromatography.
Concentration
2.0 mg/ml
Storage & Handling
This antibody should be handled aseptically as it is free of preservatives such as Sodium Azide. Store this antibody undiluted between 2°C and 8°C. Please note the storage condition for this antibody has been changed from -20°C to between 2°C and 8°C. You can also check the vial label or CoA to find the proper storage conditions.
Application

FC - Quality tested
IHC, WB, ELISA, IP - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

This antibody is effective in immunoblotting (WB), immunohistochemistry (IHC), ELISA, immunoprecipitation (IP), and flow cytometry (FC).

6D11 reacts with both the PrPc and PrPsc forms. The epitope falls within amino acids 93-109 of PrP.

Application References

(PubMed link indicates BioLegend citation)
  1. Kondoh G, et al. Angiotensin-converting enzyme is a GPI-anchoredprotein releasing factor crucial for fertilization. Nat Med 11(2):160-66, 2005. (IHC)
  2. Gilch S, et al. Recognition of lumenal prion proetin aggregates bypost-ER quality control mechanisms is mediated by the preoctarepeat region of PrP. Traffic 5:300-313, 2004. (WB, IHC, ELISA)
  3. Nishina K, et al. In vitro prion protein conversion in detergentsolubilized membranes. Biochem 43:2613-2621, 2004. (IP)
  4. Shiga Y, et al. Diffusion-weighted MRI abnormalities as an early marker for Creutzfeldt-Jakob disease. Neurol 63:443-449, 2004. (WB, IHC, IP, ELISA)
  5. Zou W, et al. Antibody to DNA detects scrapie but not normal prion protein. PNAS 101(5):1380-1385, 2004.
  6. Kitamoto T, et al. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 57:230-236, 1987.
  7. Kascsak, et al. Mouse polyclonal and monoclonal antibody to scrapie associated fibril proteins. J Virol 61:3688-3693, 1987.
  8. Spinner DS, et al. 2007. J. Leuko. Biol. 81:1374. (IHC, WB)
Product Citations
  1. Wu B et al. 2017. eLife. 6 pii: e23473. PubMed
  2. Evangelisti E, et al. 2012. J Cell Sci. 2416:125. PubMed
  3. Ribes JM, et al. 2023. Nat Commun. 8354:14. PubMed
  4. Kostelanska M, et al. 2022. Molecules. 27:. PubMed
  5. Fremuntova Z, et al. 2020. Biol Cell. 112:1. PubMed
  6. Lee JY, et al. 2017. Sci Rep. 7:8958. PubMed
  7. Uchiyama K, et al. 2021. Int J Mol Sci. 22:. PubMed
  8. Moda F, et al. 2015. PLoS Pathog. 11: 1005354. PubMed
  9. Marshall K, et al. 2017. J Virol. 91(2). PubMed
  10. Uchiyama K, et al. 2017. PLoS Pathogens. 13(6):e1006470. PubMed
  11. Mikhail A Kostylev et al. 2018. Molecular cell. 72(3):426-443 . PubMed
  12. Bistaffa E, et al. 2021. eLife. 10:00. PubMed
  13. Morales R, et al. 2016. Sci Rep. 6:20526. PubMed
RRID
AB_2564735 (BioLegend Cat. No. 808004)
AB_2564735 (BioLegend Cat. No. 808001)
AB_2564735 (BioLegend Cat. No. 808002)
AB_2564735 (BioLegend Cat. No. 808003)

Antigen Details

Biology Area
Cell Biology, Neurodegeneration, Neuroscience, Protein Misfolding and Aggregation
Molecular Family
Prion (CD230)
Gene ID
5621 View all products for this Gene ID
UniProt
View information about CD230 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 6    Revision Date: 07.09.2024

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account